O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-4.98%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$7.79B
AUM Growth
+$7.79B
(-11%)
Cap. Flow
-$283M
Cap. Flow
% of AUM
-3.63%
Top 10 Holdings %
Top 10 Hldgs %
37.29%
Holding
146
New
9
Increased
32
Reduced
26
Closed
16
Top Buys
| 1 |
Elevance Health
ELV
|
$147M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$91.8M |
| 3 |
AET
Aetna Inc
AET
|
$85.5M |
| 4 |
Humana
HUM
|
$84.2M |
| 5 |
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
|
$74.7M |
Top Sells
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$146M |
| 2 |
Molina Healthcare
MOH
|
$116M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
$102M |
| 4 |
IPXL
Impax Laboratories, Inc.
IPXL
|
$89.8M |
| 5 |
AbbVie
ABBV
|
$81.7M |
Sector Composition
| 1 | Healthcare | 94.69% |
| 2 | Financials | 1.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
1
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $415M | 5.28% | 3,388,386 +750,375 | +28% | +$91.8M |
|
2
Biogen
BIIB
$19.4B
| $363M | 4.63% | 1,281,200 -52,700 | -4% | -$14.9M |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $360M | 4.58% | 3,106,777 +158,200 | +5% | +$18.3M |
|
4
Boston Scientific
BSX
$156B
| $357M | 4.55% | 16,506,900 -704,800 | -4% | -$15.2M |
|
5
Amgen
AMGN
$155B
| $341M | 4.34% | 2,331,800 -104,900 | -4% | -$15.3M |
|
6
Merck
MRK
$210B
| $272M | 3.46% | 4,615,200 +1,108,400 | +32% | +$65.3M |
|
7
Incyte
INCY
$16.5B
| $209M | 2.66% | 2,082,800 +232,622 | +13% | +$23.3M |
|
|
SHPG
8
DELISTED
Shire pic
SHPG
| $205M | 2.61% | 1,203,351 +140,000 | +13% | +$23.9M |
|
9
Eli Lilly
LLY
$657B
| $201M | 2.57% | 2,739,000 +698,500 | +34% | +$51.4M |
|
|
10
AbbVie
ABBV
$372B
| $183M | 2.33% | 2,925,000 -1,304,900 | -31% | -$81.7M |
|
|
WMGI
11
DELISTED
Wright Medical Group Inc
WMGI
| $174M | 2.22% | 7,584,334 +228,101 | +3% | +$5.24M |
|
|
12
Humana
HUM
$36.5B
| $171M | 2.17% | 836,400 +412,900 | +97% | +$84.2M |
|
13
Pfizer
PFE
$141B
| $168M | 2.14% | 5,167,900 +1,635,700 | +46% | +$53.1M |
|
14
Agilent Technologies
A
$35.7B
| $165M | 2.11% | 3,629,900 -84,900 | -2% | -$3.87M |
|
|
AGN
15
DELISTED
Allergan plc
AGN
| $162M | 2.06% | 769,690 -9,000 | -1% | -$1.89M |
|
16
Vertex Pharmaceuticals
VRTX
$100B
| $159M | 2.03% | 2,159,400 +547,400 | +34% | +$40.3M |
|
17
HCA Healthcare
HCA
$94.5B
| $148M | 1.89% | 2,002,200 +690,000 | +53% | +$51.1M |
|
|
18
Elevance Health
ELV
$71.8B
| $147M | 1.87% | +1,021,600 | New | +$147M |
|
|
ARRY
19
DELISTED
Array Biopharma Inc
ARRY
| $141M | 1.8% | 16,088,800 +1,908,900 | +13% | +$16.8M |
|
20
Regeneron Pharmaceuticals
REGN
$61.5B
| $130M | 1.66% | 355,300 | – | – |
|
21
Edwards Lifesciences
EW
$47.8B
| $127M | 1.61% | 1,351,400 -21,800 | -2% | -$2.04M |
|
|
ICPT
22
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $122M | 1.55% | 1,120,000 | – | – |
|
23
Thermo Fisher Scientific
TMO
$186B
| $113M | 1.44% | 799,500 -17,000 | -2% | -$2.4M |
|
|
SGYP
24
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $111M | 1.42% | 18,241,398 +12,264,750 | +205% | +$74.7M |
|
25
Ironwood Pharmaceuticals
IRWD
$214M
| $111M | 1.41% | 7,241,300 -2,707,700 | -27% | -$41.4M |
|